Why the study?
Differences in adiponectin levels across eating disorders, obesity, constitutional thinness, and healthy controls remained unclear and fragmented.
How do adiponectin levels compare across eating disorders, obesity, constitutional thinness, and healthy controls?
How do adiponectin levels compare across eating disorders, obesity, constitutional thinness, and healthy controls?
Disorders characterized by excessive increases or decreases in BMI are associated with significant changes in adiponectin levels, suggesting it may be a marker of severely disequilibrated homeostasis.
No takes yet. Share an insight, caveat, or question.
Adiponectin may mark severe metabolic imbalance across BMI extremes in eating disorders; confirms its differential pattern versus constitutional thinness.
Tural et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: